Portman Square Capital »

Sarepta Therapeutics shares owned by Portman Square Capital

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Portman Square Capital from 13F filings

Historical chart of Portman Square Capital investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Portman Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Portman Square Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $62M 646k 96.43
2023-09-30 $22M 179k 121.22
2022-12-31 $376k 2.9k 129.58

More positions owned by Portman Square Capital

Shift4 Pmts Cl A Put Option (FOUR)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Live Nation Entertainment (LYV)
Akamai Technologies Put Option (AKAM)
Middleby Corporation Put Option (MIDD)
Peabody Energy Put Option (BTU)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
American Airls Put Option (AAL)
Seagate Technology Hldngs Pl Ord Shs Put Option (STX)
Western Digital (WDC)
Metropcs Communications Put Option (TMUS)
Meta Platforms Cl A Call Option (META)
Cleveland-cliffs Call Option (CLF)
Micron Technology Put Option (MU)
Advanced Micro Devices Call Option (AMD)

View all positions for Portman Square Capital

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics